KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $507 | -56.6% | 2,339 | -63.7% | 0.01% | -58.3% |
| Q1 2023 | $1,169 | +1.4% | 6,436 | +9.6% | 0.01% | 0.0% |
| Q4 2022 | $1,153 | -100.0% | 5,870 | -75.5% | 0.01% | -81.0% |
| Q3 2022 | $5,390,000 | +5.3% | 23,963 | -40.7% | 0.06% | +26.0% |
| Q1 2022 | $5,121,000 | -20.0% | 40,393 | -17.3% | 0.05% | -12.3% |
| Q4 2021 | $6,400,000 | +0.8% | 48,851 | -5.8% | 0.06% | -3.4% |
| Q3 2021 | $6,347,000 | +7.3% | 51,886 | 0.0% | 0.06% | +9.3% |
| Q2 2021 | $5,914,000 | -0.9% | 51,886 | +4.5% | 0.05% | -8.5% |
| Q1 2021 | $5,968,000 | +70.3% | 49,639 | +43.9% | 0.06% | +68.6% |
| Q4 2020 | $3,505,000 | +31.4% | 34,500 | 0.0% | 0.04% | +16.7% |
| Q3 2020 | $2,668,000 | -34.4% | 34,500 | -5.5% | 0.03% | -37.5% |
| Q2 2020 | $4,068,000 | +54.8% | 36,500 | 0.0% | 0.05% | +29.7% |
| Q1 2020 | $2,628,000 | – | 36,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |